09 in the first half of enterprises have exclusive varieties of rapid growth in exports - the export of proprietary Chinese medicines - pharmaceutical industries

China Product


1 June this year, China's total import and export volume of proprietary Chinese medicines 152 million U.S. dollars, down 5.79% (compared with 161 million U.S. dollars), accounting for proprietary Chinese medicine export Traditional Chinese medicine Products import and export volume of 16.67%. 2 to 4 months total import and export of proprietary Chinese medicines decreased greatly over the previous year. Proprietary Chinese medicines imported a total of 76,780,000 U.S. dollars (compared with 81.85 million U.S. dollars), down 6.19%; exports total 75.3 million U.S. dollars (compared with 79.58 million U.S. dollars), down 5.38% this year, China exports drop tendency of proprietary Chinese medicines formation.





In the first half, China's export of proprietary Chinese medicines to countries and regions 118, of which 49 countries and regions, appear to increase over the previous year, but the proprietary Chinese medicine is still the main exporter of Hong Kong, China, Japan and the United States. In the first half, exports to Hong Kong, China's top three proprietary companies are: Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd., Beijing Tong Ren Tang Co., Ltd., Beijing Tong Ren Tang Technologies Co., Ltd. Import & Export Branch.
outdoor thermometers



mini infrared thermometer


Currently, the state-owned enterprises still account for a significant export status, the first half of the top ten export enterprises, the state-owned enterprises account for seven places. Which has the exclusive species of Shandong Dong-E-Jiao Co., Ltd. and Yunnan Baiyao Group Co., rapid export growth, according to Health Insurance Association statistics, the two companies on the Hong Kong market, half the export growth rate is above 100%.





State-owned enterprises at the head Export enterprises in China totaled 470 Chinese patent medicines, reduction of 5% a year earlier. Proprietary state-owned enterprises remain the main export, the export value of 44.49 million U.S. dollars in the first half, accounting for 59% of the proprietary Chinese medicine exports, exports fell 2.6% from a year earlier, due to state-owned enterprises and their products are generally proprietary Chinese medicines with high brand reputation , large production scale, independent intellectual property rights and consumer groups are more fixed market, so a slight decline in total exports during the first half, but the decline is not.





First half of the proprietary Chinese-funded enterprises exported 13.09 million U.S. dollars, accounting for 17% of the proprietary Chinese medicine exports, exports fell 18.5% from a year earlier, exports must fall. Among them, the joint venture's export drop 13% foreign-owned enterprise exports drop 22%. Because of our traditional export markets of proprietary Chinese medicines in Hong Kong and Japan needs China more stable, so the main export markets in Japan and Hong Kong's foreign enterprises in China (Tianjin Tanabe Pharmacy Co., Ltd., empowerment Pharmaceutical Co., Ltd.) is not affected by the export of not only the contrary has increased considerably. The first half, Australia, Germany and the Philippines, demand fell, leading to export to these markets for foreign corporate performance fell significantly.